Log In
BCIQ
Print this Print this
 

AZD2811 (formerly AZD1152-hQPA)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionAccurin nanoparticle-encapsulated active metabolite of the prodrug barasertib (AZD1152), a selective inhibitor of aurora kinase B (AURKB; Aurora-B)
Molecular Target Aurora kinase B (AURKB) (Aurora-B)
Mechanism of ActionAurora kinase B inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$239.0M

$40.0M

0


 Deals Details
Get a free BioCentury trial today